Previous close | 0.0313 |
Open | 0.0313 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0313 - 0.0313 |
52-week range | 0.0310 - 0.0960 |
Volume | |
Avg. volume | 2,374 |
Market cap | 2.829M |
Beta (5Y monthly) | -1.96 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0600 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MEXICO CITY, October 03, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") is pleased to announce that its Mexican subsidiary, Jack Nathan Health Mexico, started operations of its first medical center in Mexico city, Mexico. This state-of-the-art facility will provide a wide range of comprehensive healthcare services, including: general medicine, internal medicine, pediatrics, laboratory services, nutrition counseling, psychology, ultrasound
TORONTO, September 21, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated financial results for the second quarter of fiscal 2024, six months ended July 31, 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
TORONTO, August 28, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health" or the "Company") is pleased to announce the appointment of Mr. Bharat Choudhary as the Company’s new permanent Chief Financial Officer (CFO).